Therapeutic goals in Fabry disease: Recommendations of a European expert panel, based on current clinical evidence with enzyme replacement therapy
Wanner C, Gerrnain DP, Hilz MJ, Spada M, Falissard B, Elliott PM (2019)
Publication Type: Journal article, Editorial
Publication year: 2019
Journal
Book Volume: 126
Pages Range: 210-211
Journal Issue: 3
DOI: 10.1016/j.ymgme.2018.04.004
Authors with CRIS profile
Involved external institutions
Julius-Maximilians-Universität Würzburg
Germany (DE)
École Polytechnique - Université Paris-Saclay
France (FR)
University of Turin / Università degli Studi di Torino (UNITO)
Italy (IT)
University of Paris 5 - René Descartes / Université Paris V René Descartes
France (FR)
University College London (UCL)
United Kingdom (GB)
Germany (DE)
École Polytechnique - Université Paris-Saclay
France (FR)
University of Turin / Università degli Studi di Torino (UNITO)
Italy (IT)
University of Paris 5 - René Descartes / Université Paris V René Descartes
France (FR)
University College London (UCL)
United Kingdom (GB)
How to cite
APA:
Wanner, C., Gerrnain, D.P., Hilz, M.-J., Spada, M., Falissard, B., & Elliott, P.M. (2019). Therapeutic goals in Fabry disease: Recommendations of a European expert panel, based on current clinical evidence with enzyme replacement therapy. Molecular Genetics and Metabolism, 126(3), 210-211. https://dx.doi.org/10.1016/j.ymgme.2018.04.004
MLA:
Wanner, Christoph, et al. "Therapeutic goals in Fabry disease: Recommendations of a European expert panel, based on current clinical evidence with enzyme replacement therapy." Molecular Genetics and Metabolism 126.3 (2019): 210-211.
BibTeX: Download